PLT 4.00% 72.0¢ plenti group limited

is the following...A recent trial performed in China comparing...

  1. 406 Posts.
    is the following...

    A recent trial performed in China comparing TruScreen ® with Liquid Based Cytology
    and primary HPV testing demonstrated TruSreen® to have higher sensitivity than Liquid
    Based Cytology for the detection of high-grade cervical precancer and cancer, and
    confirmed the value of TruScreen® for population screening in China.

    The test results themselves are great but I think the phrase "population screening" refers to a possible state sponsored national screening program. Which is quite outside the current distribution arrangements. I am reading between the lines but I know this has been a possibility for quite some time.
    If it comes off we are all on easy street.


    Cheers
    from a happy holder.
 
watchlist Created with Sketch. Add PLT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.